News for Coherus BioSciences, Inc. (CHRS)

Published at

Apr 17, 2025 11:53 AM

by seekingalpha.com

neutral

neutral

Coherus: Cleaning The Balance Sheet And Developing New Drugs (NASDAQ:CHRS)

Coherus BioSciences is now heavily focused on developing its pipeline, particularly casdozokitug and CHS-114. See why I rate CHRS stock a buy.

CHRS

Read more →
Published at

Apr 14, 2025 3:31 PM

by gurufocus.com

positive

positive

Coherus BioSciences (CHRS) Completes Divestiture of UDENYCA Franchise to Intas | CHRS Stock News

Coherus BioSciences (CHRS) has finalized the sale of its UDENYCA franchise to Intas Pharmaceuticals, completing a transaction initially announced in December 20

CHRS

Read more →
Published at

Apr 14, 2025 3:00 PM

by gurufocus.com

positive

positive

Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise

”“ $250 million post-close cash balance extends cash runway over two years into 2027, funding pipeline development through key data catalysts ”“ ”“ Coherus

CHRS

Read more →
Published at

Apr 1, 2025 2:00 PM

by markets.businessinsider.com

mixed

mixed

Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes

– Remaining $60 Million of outstanding convertible notes to be repurchased post-close of pending UDENYCA divestiture – REDWOOD CITY, Calif., April...

FRGAP CHRS AMGN.MX AMGN.BA AMGN AMG.DE CHSCP CHSCO CHSCN CHSCM CHSCL

Read more →
Published at

Mar 18, 2025 11:00 PM

by gurufocus.com

mixed

mixed

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

PR NewswirePLYMOUTH MEETING, Pa., March 18, 2025 Significant progress toward submitting a biologics license application (BLA) for INO-3107 as a potential t

INO CHRS AZN INO.MX 0A43.L

Read more →
Published at

Mar 12, 2025 8:23 PM

by insidermonkey.com

neutral

neutral

Coherus BioSciences, Inc. (CHRS): A Bull Case Theory

We came across a bullish thesis on Coherus BioSciences, Inc. (CHRS) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on CHRS. Coherus BioSciences, Inc.

CHRS

Read more →
Published at

Mar 11, 2025 8:02 AM

by gurufocus.com

positive

positive

Coherus BioSciences Inc (CHRS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Transition

Eugenica Product Sales (Q4 2024): $46.3 million, a 28% increase from $36.2 million in Q4 2023.Eugenica Product Sales (FY 2024): $206 million, a 62% increase fr

CHRS

Read more →
Published at

Mar 11, 2025 6:00 AM

by gurufocus.com

positive

positive

Q4 2024 Coherus BioSciences Inc Earnings Call Transcript

Mar 10, 2025 / 09:00PM GMTOperator Hello everyone and welcome to the Coherus fourth quarter year ending 2024 financial results conference call. (Operator Instru

CHRS

Read more →
Published at

Mar 11, 2025 1:52 AM

by seekingalpha.com

positive

positive

Coherus BioSciences, Inc. (CHRS) Q4 2024 Earnings Call Transcript

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2024 Earnings Conference Call March 10, 2025 5:00 PM ETCompany ParticipantsJodi Sievers - Head of IRDenny Lanfear...

CHRS

Read more →
Published at

Mar 10, 2025 11:00 PM

by gurufocus.com

mixed

mixed

Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update

”“ Annual net revenue increased 4% to $267.0 million in 2024, despite significant divestitures ”“”“ UDENYCA® net revenue increased 62% year-over-year ”“”“

CHRS SURF AMGN.MX AMGN.BA AMGN AMG.DE

Read more →
Published at

Mar 10, 2025 9:18 PM

by manilatimes.net

mixed

mixed

Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update

**media[562476]**

FRGAP CHSCP CHSCO CHSCN CHSCM CHSCL CHRS SURF AMGN.MX AMGN.BA AMGN AMG.DE

Read more →
Published at

Mar 7, 2025 1:06 PM

by gurufocus.com

positive

positive

What To Expect From Coherus BioSciences Inc (CHRS) Q4 2024 Earnings

Coherus BioSciences Inc (CHRS) is set to release its Q4 2024 earnings on March 10, 2025. The consensus estimate for Q4 2024 revenue is $47.27 million, and the e

CHRS

Read more →
Published at

Mar 3, 2025 2:50 PM

by manilatimes.net

mixed

mixed

Coherus to Report Fourth Quarter and Full Year 2024 Financial Results on March 10, 2025

**media[555576]**

CHSCP CHSCO CHSCN CHSCM CHSCL CHRS

Read more →
Published at

Feb 24, 2025 4:00 PM

by gurufocus.com

positive

positive

Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference

REDWOOD CITY, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (”Coherus,” CHRS) today announced that senior management will participa

CHRS

Read more →
Published at

Feb 24, 2025 3:25 PM

by manilatimes.net

positive

positive

Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference

**media[548703]**

COWNL COWN CHRS

Read more →
Published at

Jan 16, 2025 10:18 PM

by manilatimes.net

positive

positive

Codexis Appoints Christos Richards to Board of Directors

**media[517340,517341]**

CHRS CDXS 0I0X.L

Read more →
Published at

Jan 9, 2025 3:00 PM

by gurufocus.com

mixed

mixed

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments

PR NewswirePLYMOUTH MEETING, Pa., Jan. 9, 2025 PLYMOUTH MEETING, Pa., Jan. 9, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on

INO.MX INO CHRS 0A43.L AZN

Read more →
Published at

Dec 17, 2024 12:08 AM

by seekingalpha.com

positive

positive

Coherus BioSciences: Shedding Pegfilgrastim To Fuel Ongoing Development

Coherus BioSciences is expanding in immunotherapy while managing financial risks. Learn why CHRS stock may benefit from the company's strategic decisions.

CHRS

Read more →
Published at

Dec 5, 2024 2:53 PM

by investing.com

positive

positive

Coherus price target raised at Baird on agreement to sell Udenyca By Investing.com

Coherus price target raised at Baird on agreement to sell Udenyca

CHRS

Read more →
Published at

Dec 3, 2024 2:55 PM

by rttnews.com

mixed

mixed

Pre-market Movers: CTNT, NLSP, PSQH, JANX, CHRS…

North Carolina-based Cheetah Net Supply Chain Service Inc. (CTNT) is up over 267 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

NLSPW NLSP JANX CLSK CHRS VMAR VIR

Read more →